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General Experimental Details 
Reaction mixtures were stirred magnetically. Air- and moisture-sensitive reactions were carried out in 
flame-dried glassware under argon atmosphere by using standard Schlenk manifold techniques. Fine 
chemicals were purchased from Acros Organics, Alfa Aesar, Inochem-Frontier Scientific or Sigma-
Aldrich and used as received unless otherwise mentioned. n-Butyllithium (nBuLi) was received from 
Acros Organics as a 1.3 M solution in cyclohexane/hexane 92:8 and the molarity was verified by 
titration with N-benzylbenzamide.1 TMEDA was distilled over CaH2 before use; (‒)-sparteine and (+)-
sparteine were isolated from the commercially available sulfate salt following a procedure by Beak.2 
Petrol refers to the fraction of petroleum ether boiling at 40–60 °C. Anhydrous THF, CH2Cl2, toluene, 
hexane, acetonitrile and Et2O were dried by passing through a modified Grubbs system3 of alumina 
columns, manufactured by Anhydrous Engineering and were transferred under argon via syringe. 
Microwave reactions were carried out in a Biotage Initiator EXP EU microwave synthesiser. 1H Nuclear 
Magnetic Resonance (NMR) spectra were recorded in CDCl3 at 300, 400 or 500 MHz on a Joel Lambda 
300, Joel ECP 400, a Varian 400-MR or a VNMRS500a Fourier transform spectrometer. Chemical 
shifts (δH) are quoted in parts per million (ppm) and referred to the residual protio solvent signals of 
CHCl3 (7.27 ppm). 1H NMR coupling constants are reported in hertz and refer to apparent multiplicities. 
Data are reported as follows: chemical shift, multiplicity (s = singlet, br. s = broad singlet, d = doublet, 
t = triplet, q = quartet, quin = quintet, sext = sextet, sept = septet, m = multiplet, dd = doublet of doublet, 
etc.), coupling constant, integration, and assignment. 13C NMR spectra were recorded at 101 or 126 
MHz. Chemical shifts (δC) are quoted in ppm and referenced to CHCl3 (77.0 ppm) or acetone (29.92 
ppm). 11B NMR spectra were measured using Norell S-200-QTZ quartz NMR tubes at 96 or 128 MHz 
with complete proton decoupling. 19F NMR spectra were recorded at 283, 376 or 470 MHz. Mass 
spectra were recorded by the University of Bristol, School of Chemistry departmental mass 
spectrometry service using electron impact ionisation (EI), chemical ionisation (CI) or electrospray 
ionisation (ESI) techniques for low- and high-resolution mass spectra. HRMS EI and CI were performed 
on a VG Analytical Autospec mass spectrometer at 70 eV. HRMS ESI was performed on either a Bruker 
Daltonics Apex IV, 7-Tesla FT-ICR or microTOF II. Samples were submitted in EtOAc. For low- 
resolution mass spectra (m/z) only molecular ions (M+ or M+H+) and major peaks are reported with 
intensities quoted as percentage of the base peak. All infrared spectra were recorded on the neat 
compounds using a PerkinElmer Spectrum One FT-IR spectrometer, irradiating between 4000 cm‒1 and 
600 cm‒1. Only strong and selected absorbance values (νmax) are reported. Analytical TLC was 
performed on aluminium-backed silica plates (Merck, Silica Gel 60 F254, 0.25 mm). Compounds were 
visualised by fluorescence quenching or by staining the plates with 5% solution of phosphomolybdic 
acid (H3PMo12O40) in EtOH followed by heating. Flash column chromatography was performed on 
silica gel (Aldrich, Silica Gel 60, 40‒63 µm). All mixed solvent eluents are reported as v/v solutions. 
Optical rotations were obtained using a Bellingham + Stanley Ltd. ADP220 polarimeter at 589 nm (Na 
D-line) in a cell with a path length of 1 dm. Specific rotation values are given in (deg mL)/(g dm). 
Melting points were measured with a Reichert hot stage apparatus and are uncorrected. The ee values 
of boronic ester products were determined through standard oxidation to the corresponding alcohol (see 
page S38) followed by either chiral HPLC or SFC analysis. Chiral high performance liquid 
chromatography (HPLC) separations were performed on an Agilent 1100 Series HPLC unit equipped 
with UV-vis diode-array detector monitored at 210.8 nm, using Daicel Chiralpak ADH, IA, IB or IC 
columns (4.6 × 250 mm2, 5 µm) fitted with respective guards (4 × 10 mm2). Chiral supercritical fluid 
chromatography (SFC) was performed using Diacel Chiralpak IA, IB and IC columns (4.6 × 250 mm 
× 5 μm) or a Whelk O-1 column (4.6 × 250 mm × 5 μm) on a Waters TharSFC system and monitored 
by DAD (diode array detector). 
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Synthesis of Primary Benzoates 
General Procedure 1 (GP1): Benzoate synthesis from a primary alkyl bromide 
Following Beak’s procedure,4 a biphasic mixture of 2,4,6-triisopropylbenzoic acid (20.2 g, 
81.3 mmol, 1.0 eq.), NBu4(HSO4) (2.21 g, 6.5 mmol, 0.08 eq.), NaOH (10.1 g, 252.0 mmol, 
3.1 eq.) and primary alkyl halide (81.3 mmol, 1 eq.) in CHCl3 (400 mL) and H2O (320 mL) 
was stirred overnight at room temperature. The phases were separated and the aqueous phase 
extracted with CH2Cl2 (3 × 100 mL). The combined organic phases were washed with brine 
(300 mL), dried (MgSO4) and concentrated under reduced pressure. The crude product was 
dissolved in pentane (60 mL) and the insoluble salts filtered off. The solvent was removed from 
the filtrate under reduced pressure to give benzoate ester which was used without further 
purification. 
General procedure 2 (GP2): Benzoate synthesis from a primary alcohol 
To a stirred solution of PPh3 (11 mmol), secondary alcohol (10 mmol) and 2,4,6-
triisopropylbenzoic acid (11.5 mmol) in THF (15 ml) at 0 °C (ice bath), was added DIAD (11 
mmol) dropwise over 10 min. After stirring the mixture for 4 h at 0 °C (ice bath), the volatiles 
were removed in vacuo. The residue was dissolved in pentane (15 ml) and the resulting solution 
stirred in for 5 min. The white suspension was filtered and the filter cake washed with pentane 
(100 ml). The solvent was removed in vacuo and the residue purified by flash column 
chromatography to give pure benzoate. 
3-(2,5-dimethyl-1H-pyrrol-1-yl)propyl 2,4,6-triisopropylbenzoate (41) 
Using GP2 and 3-(2,5-dimethyl-1H-pyrrol-1-yl)propan-1-
ol5 (1.5 g, 9.8 mmol) gave benzoate 41 (3.325 g, 89 %) after 
purification by column chromatography (10% Et2O/pentane) 
as a colourless oil. 
1H NMR (400 MHz, CDCl3): 7.02 (s, 2H), 5.78 (s, 2H), 4.35 (t, J 6.2, 2H), 3.88 (m, 2H), 2.90 
(hept, J 6.9, 1H), 2.84 (hept, J 6.9, 2H), 2.22 (s, 6H), 2.05 (m, 2H), 1.26 (app. d, J 6.9, 18H). 
13C NMR (101 MHz, CDCl3): 170.9, 150.4, 144.9, 130.3, 127.4, 120.9, 105.5, 62.3, 40.7, 34.4, 
31.6, 30.2, 24.2, 23.9, 12.5. 
IR (film): ʋ (cm-1). 2958, 1720, 1251. 
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HRMS (ESI) calc. C25H38NO2 [M+H]
+ 384.2897, found 384.2912. 
 
pent-4-en-1-yl 2,4,6-triisopropylbenzoate (42) 
Using GP1 and 5-bromopent-1-ene (5 mL, 40 mmol) gave 
benzoate 42 (8.12 g, 64%). 
1H NMR (400 MHz, CDCl3): 7.01 (s, 2H), 5.82 (ddt, J 16.9, 
10.2, 6.7, 1H), 5.05 (dq, J 16.9, 1.4, 1H), 5.01 (dq, J 10.2, 1.6, 1H), 4.31 (t, J 6.6, 2H), 2.95 – 
2.76 (m, 3H), 2.18 (q, J 6.8, 2H), 1.83 (p, J 6.8, 2H), 1.25 (d, J 6.9, 12H), 1.24 (d, J 7.0, 6H). 
13C NMR (101 MHz, CDCl3): 170.9, 150.1, 144.7, 137.3, 130.6, 120.8, 115.4, 64.3, 34.4, 31.5, 
30.1, 27.8, 24.1, 23.9. 
IR (film): ʋ (cm−1) 2960, 2930, 2870, 1724, 1606, 1462, 1250, 1137, 1074, 912, 876. 
HRMS (ESI) calc. C21H32O2Na [M+Na]
+ 339.2295, found 339.2295 
 
(4R)-4-((5R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentyl 2,4,6-
tritriisopropylbenzoate (43) 
 
Using GP2 and (4R)-4-((5R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentan-1-ol6 (3.01 g, 6.32 mmol) 
gave benzoate 43 (2.60 g, 58%) after column chromatography (20 % DCM/pentane). 
1H NMR (400 MHz, CDCl3): 7.00 (s, 2H), 4.33–4.21 (m, 2H), 3.58 (m, 1H), 1.95 (d, J 12.0, 
1H), 1.87–1.71 (m, 5H), 1.64–1.29 (s, 13H), 1.28–1.00 (m, 27H), 0.92 (d, J 6.5, 3H), 0.89 (s, 
3H), 0.89 (s, 9H), 0.63 (s, 3H), 0.06 (s, 6H). 
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13C NMR (101 MHz, CDCl3): 171.03, 149.95, 144.68, 130.73, 120.78, 72.82, 65.62, 56.39, 
56.27, 42.69, 42.29, 40.20, 40.16, 36.91, 35.85, 35.57, 35.54, 34.58, 34.40, 32.29, 31.46, 31.01, 
28.32, 27.29, 26.39, 25.97, 25.45, 24.19, 24.17, 24.14, 23.94, 23.38, 20.80, 18.48, 18.33, 12.01, 
−4.61. 
IR (film): ʋ (cm-1) 2927, 2862, 1725, 1606, 1461, 1381, 1249, 1136, 871, 834, 772, 667. 
HRMS (ESI) calc. C46H78O3SiNa [M+Na]
+ 729.5612, found 729.5607. 
[α]D23 +24 (c 1, CHCl3) 
 
pent-4-yn-1-yl 2,4,6-triisopropylbenzoate (44) 
Using GP2 and pent-4-yn-1-ol (3 mL, 32 mmol) gave benzoate 
44 (7.36 g, 74%) after purification by column chromatography 
(1% Et2O/pentane). 
1H NMR (400 MHz, CDCl3): 7.01 (s, 2H), 4.41 (t, J 6.3, 2H), 2.89 (hept, J 6.9, 1H), 
2.85 (hept, J 6.8, 2H), 2.34 (td, J 7.0, 2.6, 2H), 1.99 (t, J 2.6, 1H), 1.95 (p, J 6.9, 2H), 1.25 (d, 
J 6.9, 18H). 
13C NMR (101 MHz, CDCl3): 170.8, 150.1, 144.7, 130.4, 120.8, 82.7, 69.2, 63.3, 34.4, 31.5, 
27.4, 24.1, 23.9, 15.2. 
IR (film): ʋ (cm-1) 3290, 2961, 2930, 2871, 1725, 1606, 1249, 1073, 876, 631. 
HRMS (ESI) calc. C21H30O2Na [M+Na]
+ 337.2138, found 337.2141. 
 
3-((tert-butyldimethylsilyl)oxy)propyl 2,4,6 triisopropylbenzoate (45) 
Using GP2 and 3-((tert-butyldimethylsilyl)oxy)propan-1-ol7 
(0.089 g, 0.47 mmol) gave benzoate 45 (0.135 g, 68 %) after 
purification by column chromatography (1% Et2O/pentane) 
as a colourless oil. 
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1H NMR (400 MHz, CDCl3): 7.00 (s, 2H), 4.40 (t, J 6.2, 2H), 3.72 (t, J 6.2, 2H), 2.88 (sept, J 
6.9, 1H) 2.84 (sept, J 6.9, 2H), 1.93 (p, J 6.2, 2H), 1.24 (d, J 6.7, 18H), 0.89 (s, 9H), 0.05 (s, 
6H).  
13C NMR (101 MHz, CDCl3): 171.0, 150.1, 144.8, 130.7, 120.9, 62.1, 59.6, 34.5, 32.0, 31.6, 26.0, 
24.2, 24.0, 18.3, −5.3. 
IR (film): ʋ (cm-1). 2958.3, 2869.2, 1726.0, 1462.1, 1250.4, 1073.4 and 835.7. 
HRMS (ESI) calc. C25H44NaO3Si [M+Na]
+ 443.2952, found 443.2940. 
 
Synthesis of Stannyl Benzoates 
General Procedure 3 (GP3) 
The requisite alkyl 2,4,6-triisopropylbenzoate (1.0 eq.) and (+)-sparteine (1.3 eq.) were 
dissolved in anhydrous diethyl ether (0.33 M) and cooled to 78 °C. sBuLi (1.3 M in hexanes, 
1.3 eq.) was added dropwise and the reaction mixture was stirred at this temperature for 3–5 h. 
A trialkyltin chloride (1.5 eq) was added at −78 °C, and after 5 minutes the reaction mixture 
was warmed to room temperature. The reaction mixture was diluted with Et2O (10 mL/mmol) 
and washed with equal volume of 1 M aq. HCl. The organic layer was separated, dried over 
MgSO4, filtered, concentrated in vacuo and the residue purified by column chromatography. 
Racemic samples were prepared using TMEDA in place of (+)-sparteine. 
(R)-3-(4-methoxyphenyl)-1-(tributylstannyl)propyl 2,4,6-triisopropylbenzoate (46)  
Using GP3, 3-(4-methoxyphenyl)propyl-2,4,6-
triisopropylbenzoate8 (3.00 g, 7.5 mmol) and tributyltin 
chloride (2.7 mL, 9.75 mmol) gave 46 (3.78 g, 73%) 
after column chromatography (5% Et2O/pentane). 
1H NMR (400 MHz, CDCl3): 7.09 (d, J 8.6, 2H), 7.01 (s, 2H), 6.84 (d, J 8.6, 2H), 5.17 (dd, J 
9.0, 4.0, 1H), 3.79 (s, 3H), 2.97–2.80 (m, J 6.8, 3H), 2.73 (ddd, J 15.4, 10.7, 4.9, 1H), 2.61 
(ddd, J 13.6, 10.5, 6.0, 1H), 2.23 (m, 1H), 2.10 (m, 1H), 1.62 – 1.40 (m, 6H), 1.31 (p, J 7.3, 
6H), 1.26 (d, J 6.7, 12H), 1.25 (d, J 6.8, 6H), 1.01–0.93 (m, 6H), 0.89 (t, J 7.3, 9H). 
13C NMR (100 MHz, CDCl3,): 171.1, 157.8, 149.8, 144.8, 133.8, 130.9, 129.2, 120.8, 113.8, 
71.5, 55.2, 36.8, 34.4, 33.8, 31.5, 29.1, 27.5, 24.6, 24.2, 23.9, 13.7, 9.8. 
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IR (film): ʋ (cm−1) 2957, 2925, 2870, 2854, 1706, 1608, 1512, 1245, 1068, 876, 819. 
HRMS (ESI) calc. C38H62NaO3Sn [M+Na]
+ 709.3621, found 709.3604. 
[α]D22 = −27 (c 1, CHCl3). 
Despite much effort, an ee value could not be obtained for this compound owing to poor 
separation of the racemate into enantiomers by using chiral HPLC.  However, the high d.r value 
obtained in its use for the synthesis of C2-symmetric 1,3-bis(boronic ester) 4, suggests that the 
ee value is >95:5; a value of 96:4 is typical for the asymmetric deprotonation of similar 
benzoate esters.  
(S)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate (47)  
 
According to GP3 ethyl 2,4,6-triisopropyl benzoate9 (14 g, 60 mmol, 1 
eq.), (−)-sparteine (17 mL, 74 mmol, 1.2 eq.) and trimethyltin chloride 
(1 M in hexanes, 80 mL, 80 mmol, 1.3 eq.) gave a yellow solid (~95:5 
er) after work up, which was purified and enriched by recrystallization 
(MeOH 4mL/g) giving 47 as long cubic prisms (61%, 16.2 g, >99:1 er) and a second crop of 
crystals from the mother liquor (25%, 6.6 g, 92:8 er). 
 
M.p. 64–65 ºC (MeOH), Lit.9 65–66 °C (MeOH) 
1H NMR (CDCl3, 400 MHz): 6.99 (s, 2H), 5.04 (q, J 6.9, 1H), 2.80–2.95 (m, 3H), 1.58 (m, 
3H), 1.24 (d, J 6.9, 18H), 0.18 (s, d, J 54.1, and d, J 51.7, 9H). 
13C NMR (CDCl3, 100 MHz): 173.3, 149.9, 144.8, 120.8, 67.0, 34.4, 31.3, 24.3, 24.1, 24.1, 
23.9, −9.9. 
[α]D22 = +40 (c. 1, CHCl3), Lit.9 [α]D20 = +38.3 (c. 1.1, CHCl3) 
Chiral HPLC (IB , hexane, 0.7 mL/min, RT) tR = 7.5 (major) and 10.0 (minor). 
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(R)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate (ent-47) 
 
According to GP3 using ethyl 2,4,6-triisopropylbenzoate (5.5 g, 30 
mmol, 1 eq.),9 (+)-sparteine surrogate (6.7 g, 37 mmol, 1.2 eq.) or (+)-
sparteine (9.1 g, 37 mmol, 1.2 eq.), and trimethyltin chloride (1 M in 
hexanes, 40 mL, 40 mmol, 1.3 eq.) gave a yellow solid, which was 
purified and enriched by recrystallization (MeOH 4mL/g) giving ent-47 as long cubic prisms 
(62 %, 5.3 g, >99:1 er) and a second crop of crystals from the mother liquor (20%, 1.7 g, 87:13 
er).  
M.p. 64–65 °C (MeOH) 
[α]D22 = −40 (c. 1, CHCl3) 
Chiral HPLC (IB, hexane, 0.7 mL/min, RT), tR = 7.7 (minor) and 10.4 (minor). 
 
 
(R)-3-phenyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate (48) 
 
Using GP3, 3-phenylpropyl-2,4,6-triisopropylbenzoate10 
(2.31 g, 6.3 mmol) and trimethyltin chloride (6.0 mL, 9.5 
mmol, 1.57 M in hexane) gave 48 (1.66 g, 50%, 95:5 er) after column chromatography (3% 
Et2O/pentane). 
1H NMR (400 MHz, CDCl3): 7.30 (m, 2H), 7.24–7.14 (m, 3H), 7.02 (s, 2H), 5.01 (m, 1H), 
2.97–2.84 (m, 3H), 2.81 (ddd, J 13.4, 10.7, 5.9, 2H), 2.68 (ddd, J 13.4, 10.7, 5.9, 2H), 2.32–
2.08 (m, 2H), 1.27 (12H, d, J 6.8), 1.26 (6H, d, J 6.9), 0.22 (s, d, J 53.9 and d, J 51.6, 9H). 
13C NMR (101 MHz, CDCl3): 171.4, 150.0, 144.9 , 141.6, 130.6, 128.4, 128.3, 125.9, 120.9, 
71.8, 36.0, 34.4, 34.4, 31.5, 24.4, 24.3, 23.9, −9.0. 
[α]D22 = −36 (c 1, CHCl3). 
IR (film): ʋ (cm-1) 2961, 2931, 2868, 1704, 1606, 1573, 1248, 1068, 766, 698. 
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HRMS (ESI) calc. C28H42NaO2Sn [M+Na]
+ 553.2104, found 553.2091. 
Chiral HPLC (IA, 97.5:2.5 hexane:IPA, 1 mL/min, RT) 
 
3-((tert-butyldimethylsilyl)oxy)-1-(trimethylstannyl)propyl 2,4,6 triisopropylbenzoate 
(49) 
 Using GP3 and benzoate 45 (2.00 g, 4.75 mmol) gave 
stannyl benzoate 49 (2.40 g, 87%, 95:5 er) after purification 
by column chromatography (4% Et2O/pentane) as a 
colourless oil. 
1H NMR (400 MHz, CDCl3): 6.99 (s, 2H), 5.07 (dd, J 9.4, 4.2, 1H), 3.64-3.75 (m, 2H), 2.88 
(hept, J 6.8, 1H), 2.81 (hept, J 6.8, 2H), 2.15 (m, 1H), 2.03 (dtd, J 14.3, 7.10, 7.10, 4.3, 1H), 
1.24 (d, J 7.00, 6H), 1.23 (d J 7.00, 12H), 0.89 (s, 9H), 0.20 (s and d, J 54 and d, J 51, 9H), 
0.04 (s, 6H).   
13C NMR (101 MHz, CDCl3): 171.4, 150.0, 145.0, 130.8, 121.0, 68.7, 61.1, 37.0, 34.5, 31.6, 
26.1, 24.5, 24.1, 18.5, −5.2, −8.8.  
[α]D22 =  34 (c = 1.0, CHCl3) 
IR (film): ʋ (cm-1) 2959, 2928, 2859, 1705, 1251, 1099, 835. 
HRMS (ESI) calc. C28H52NaO3SiSn [M+Na]
+ 607.2605, found 607.2603. 
CHIRAL HPLC (Chiralpak IB, hexane, 1 ml/min, RT) tR: 5.63 min (minor), 6.54 min (major), 
er 95:5. 
 
  
min2 2.5 3 3.5 4 4.5 5 5.5
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400
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1000
1200
1400
 DAD1 C, Sig=210,8 Ref=360,100 (DANIEL\DJB10484.D)
min2 2.25 2.5 2.75 3 3.25 3.5 3.75 4
mAU
0
200
400
600
800
1000
1200
 DAD1 C, Sig=210,8 Ref=360,100 (DANIEL\DJB10441.D)
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(R)-1-(trimethylstannyl)pent-4-en-1-yl 2,4,6-triisopropylbenzoate (50) 
Using GP3, benzoate 42 (2.31 g, 6.3 mmol) and trimethyltin 
chloride (6.0 mL, 9.5 mmol, 1.57 M in hexane) gave 50 (1.56 
g, 51%, 95:5 er) after column chromatography (1% 
Et2O/pentane). 
1H NMR (400 MHz, CDCl3):  7.00 (s, 2H), 5.81 (ddt, J 16.9, 10.2, 6.5, 1H), 5.07–4.93 (m, 
2H), 2.95–2.76 (m, 3H), 2.28–2.09 (m, 2H), 2.04 (dtd, J 14.4, 8.8, 5.5, 1H), 1.93 (dddd, J 14.4, 
9.9, 6.1, 4.9, 1H), 1.26–1.22 (d, J 6.9, 18H), 0.20 (s, d J 53.9 and d, J 51.6, 9H). 
13C NMR (101 MHz, CDCl3): 171.3, 149.9, 144.8, 137.7, 130.7, 120.8, 115.1, 71.6, 34.4, 33.2, 
31.9, 31.4, 24.4, 24.2, 23.9, –9.1. 
IR (film): ʋ (cm-1) 2962, 2928, 2872, 1705, 1462, 1249, 1075, 769 
HRMS (ESI) calcd. for C24H40NaO2Sn [M+Na]
+ 503.1947, found 503.1927.  
[α]D22 = −41 (c 1, CHCl3). 
The enantiomeric ratio of 50 was determined through tin–lithium exchange and reaction with 
4,4,5,5-tetramethyl-2-phenethyl-1,3,2-dioxaborolane as outlined below. Subsequent oxidation 
and chiral HPLC separation as previously described11 showed the er to be 95:5. 
 
Chiral HPLC (Chiralpak IB, 95:5 hexane:IPA, 0.5 ml/min, RT) tR: 15.09 min (minor), 20.14 
min (major), er 95:5. 
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(R)-2-methyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate (51) 
Using GP3, isobutyl 2,4,6-triisopropylbenzoate10 (1.9 g, 6.3 mmol) 
and trimethyltin chloride (6.0 mL, 9.5 mmol, 1.57 M in hexanes) 
gave 51 (1.25 g, 42%, ≥96:4 er) after column chromatography (1% 
Et2O/pentane). 
1H NMR (400MHz, CDCl3): 7.00 (s, 2H), 4.97 (m, 1H), 2.93–2.79 (m, 3H), 2.25 (m, 1H), 
1.25 (d, J 6.9, 6H), 1.24 (d, J 6.9, 6H), 1.23 (d, J 7.0, 6H), 1.04 (d, J 6.7, 3H), 1.00 (d, J 6.8, 
3H), 0.21 (s, d, J 53.6 and d, J 51.4, 9H). 
13C NMR (101 MHz, CDCl3): 171.4, 149.8, 144.9, 130.8, 120.8, 79.4, 34.3, 32.6, 31.4, 24.4, 
24.2, 23.9, 21.3, 19.8, −8.0. 
IR (film): ʋ (cm−1) 2960, 2928, 2872, 1703, 1609, 1576, 1250, 1138, 1075, 1065, 876, 766. 
HRMS (ESI) calc. C23H40NaO2Sn [M+Na]
+ 491.1947, found 491.1650. 
[α]D22 = −27 (c 1, CHCl3). 
Chiral HPLC (Chiralpak IB, hexane, 1 ml/min, RT) tR: 4.24 min (minor), 5.38 min (major), 
er 96:4. 
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Synthesis of Secondary Benzylic Carbamates 
 
 
NaBH4 (567 mg, 15.0 mmol, 1.5 eq.) was added portion-wise to a solution of ketone (10.0 mmol, 1 eq.) 
in MeOH (7 mL) and THF (10 mL) at 0 °C over 5 minutes with vigorous stirring. The reaction was 
warmed to RT and stirred for 30 min at which point TLC indicated complete consumption of starting 
material. The reaction was quenched by addition of saturated aq. NH4Cl (5 mL) and diluted with H2O 
(10 mL) and EtOAc (100 mL). The layers were separated and the organic layer was washed sequentially 
with H2O (15 mL) and brine (2 × 15 mL). The organic layer was dried over MgSO4, filtered, 
concentrated in vacuo and used without further purification. To a solution of racemic benzylic alcohol 
(9.8 mmol, 1 eq.) in diisopropyl ether (4 mL) was added acrylic-resin-bound lipase from Candida 
Antarctica (59 mg, 6 mg per mmol of alcohol) followed by vinyl acetate (4.3 mL, 49 mmol 5 eq.). The 
suspension was then heated to 50 °C, stirred for 16 h at which point 1H NMR analysis of a filtered 
aliquot indicated  ≥50% conversion. The reaction mixture was filtered through a plug of SiO2, which 
was washed with EtOAc. The filtrate was concentred in vacuo and purified by flash column 
chromatography (20% EtOAc:petrol) to give the enantioenriched (S)-alcohol and (R)-acetate products. 
To a solution of the enantioenriched benzylic alcohol (3.47 mmol, 1.00 eq.) in PhMe (3.5 mL) in a 
sealable microwave vial under N2 was added N,N-diisopropylcarbamoyl chloride (681 mg, 4.16 mmol, 
1.20 eq.) followed by Et3N (0.63 mL, 4.51 mmol, 1.30 eq.). The vial was then sealed and heated under 
microwave irradiation at 150 °C for 2 h.* The reaction mixture was then cooled to room temperature, 
filtered through a plug of SiO2 with Et2O, concentrated in vacuo and purified by column 
chromatography to afford secondary carbamates in >99:1 er. * The reaction can be performed under 
standard reflux by replacing the PhMe with DCM (0.5 M) for 24–48h. Analytical data for the 
carbamates below can be found in the supporting information of previous work.12–15 
  
S14 
 
Synthesis of 1,2-bis(boronic esters) 
General Procedures 
General procedure for single homologation of diborylmethane 1 using primary benzoates 
(GP4) 
A solution of alkyl 2,4,6-triisopropylbenzoate (1.0 eq.) and (+)-sparteine (1.2 eq.) in anhydrous 
diethyl ether (0.33 M) was cooled to 78 °C. sBuLi (1.3 M in hexanes,1.2 eq.) was added 
dropwise and the reaction mixture was stirred at this temperature for 3–5 h. A solution of 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (1.5 eq.) in anhydrous diethyl ether 
(0.75 M) was added dropwise and the mixture was stirred for 1 h at 78 °C. Afterwards, the 
cooling bath was removed and the reaction mixture was heated at 40 °C overnight (16 h). The 
reaction mixture was cooled to room temperature, diluted with water and extracted with Et2O. 
The combined organic phases were washed with 1 M HCl solution, dried over MgSO4, filtered 
and concentrated in vacuo. The crude material purified by flash chromatography on silica gel 
to give the 1,2-bis(boronic ester). Racemic samples were prepared using TMEDA or nBu-
bispidine in place of (+)-sparteine. 
(R)-2,2'-(4-(4-methoxyphenyl)butane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (3) 
Following GP4 with 3-(4-methoxyphenyl)propyl 2,4,6-
triisopropylbenzoate8 (0.63 mmol, 250 mg), gave 3 as a 
colourless oil (71%, 242 mg, 97:3 er). 
1H NMR (400 MHz, CDCl3): 7.09 (app. d, J 8.8, 2H), 6.80 (app. d, J 8.8, 2H), 3.77 (s, 3H), 
2.55 (t, J 8.2, 2H), 1.60 (m, 1H), 1.75 (m, 1H), 1.25 (s, 12H), 1.23 (s, 12H), 1.18 (m, 1H), 0.93 
(dd, J 15.7, 9.4, 1H), 0.86 (dd, J 15.7, 5.9, 1H). 
13C NMR (100 MHz, CDCl3): 157.5, 135.4, 129.2, 113.6, 82.8, 55.2, 36.2, 34.4, 24.9, 24.9, 
24.8, 18.3, 12.4. 
IR (film): ʋ (cm−1) 2977, 2929, 1614, 1512, 1370, 1311, 1244, 1140, 967, 845, 824, 671. 
HRMS (ESI) calcd. for C23H38B2NaO5 [M+Na]
+439.2806, found 439.2802.  
[α]D22 = −7  (c 1, CHCl3). 
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Chiral SFC: Chiralcel IB , 125 bar, 42°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 
13.57 min (minor), 14.17 min (major). 
 
 
 
 
(R)-1-(3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)-2,5-dimethyl-1H-
pyrrole (5) 
Using GP4 and benzoate 41 (1.50 g, 3.91 mmol) gave 1,2-
bis(boronic ester) 5 (0.987 g, 63 %, 97:3 er) after purification by 
column chromatography (10 % Et2O/pentane) as a pale yellow oil.    
1H NMR (400 MHz, CDCl3): 5.73 (s, 2H), 3.81 – 3.64 (ABddd, 2H), 2.22 (s, 6H), 1.78 – 
1.68 (m, 1H), 1.68 – 1.59 (m, 1H), 1.24 (d, J = 6.3 Hz), 1.23 – 1.71 (m, 1H), 0.97 (dd, J = 
15.9, 8.9 Hz, 1H), 0.86 (dd, J = 15.9, 6.1 Hz, 1H) 
13C NMR (101 MHz, CDCl3): 127.4 (C), 104.8 (CH), 83.3 (C), 83.2 (C), 43.4 (CH2), 34.8 
(CH2), 25.0 (CH3), 24.9 (CH3), 12.5 (CH3) carbons attached to boron not observed.  
[α]D22 = +1 (c = 1.0, CHCl3) 
IR (film): ʋ (cm-1) 2976, 2929, 1519, 1409, 1369, 1314, 1140. 
HRMS (ESI) calc. C22H39B2NaNO4 [M+Na]
+ 426.2965, found 426.2966. 
CHIRAL HPLC: (Chiralpak IB, 50:50 hexane:IPA, 1 ml/min, RT) tR: 4.23 min (minor), 5.48 
min (major), er 97:3. 
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(R)-2,2'-(hex-5-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (6) 
 Following GP4 with benzoate 42 (0.25 mmol, 79 mg), gave 6 as a 
colourless oil (74%, 62 mg, 97:3 er). The ee value was determined through oxidation and 
formation of the corresponding dimethyl acetal. 
1H NMR (400 MHz, CDCl3): 5.81 (ddt, J 17.1, 10.2, 6.7, 1H), 4.98 (dq, J 17.1, 1.5, 1H), 4.89 
(d, J 10.2, 1H), 2.06 (app. q, J 7.2, 2H), 1.56 (m, 1H), 1.40 (m, 1H), 1.23 (s, 12H), 1.22 (s, 
12H), 1.14 (p, J 6.7, 1H), 0.85 (m, 2H). 
13C NMR (101 MHz, CDCl3): 139.4, 114.0, 82.8, 82.8, 33.1, 33.1, 24.9, 24.8, 24.8, 24.7, 
carbons attached to boron not observed. 
IR (film): ʋ (cm-1) 3076, 2978, 2926, 1640, 1369, 1312, 1142, 968, 848, 671. 
HRMS (ESI) calcd. for C18H34B2NaO4 [M+Na]
+ 359.2542, found 359.2545.  
[α]D22 = −1  (c 1, CHCl3). 
Chiral GC: β-Dextrose column, 50 °C isocratic, 0.1 mL/min; tR: 37.01 min (minor), 37.14 min 
(major), er 97:3. 
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(((3R,5R,8R,9S,10S,13R,14S,17R)-17-((2R,5S)-5,6-bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hexan-2-yl)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthren-3-yl)oxy)(tert-butyl)dimethylsilane (7) 
Following GP4 with benzoate 43 (0.33 mmol, 
233 mg) gave 7 as a colourless oil (73%, 228 mg, 
>20:1 dr). 
1H NMR (400 MHz, CDCl3): 3.59 (m, 1H), 1.94 
(app. d, J 12.0, 1H), 1.73–1.86 (m, 4H), 1.49–
1.57 (m, 2H), 1.28–1.43 (m, 11H), 1.27–1.17 (m, 
27H), 1.01–1.15 (m, 8H), 0.91–0.85 (m, 16H), 0.80 (dd, J 15.7, 6.1, 1H), 0.61 (s, 3H), 0.06 (s, 
6H). 
13C NMR (100 MHz, CDCl3): 82.7, 82.7, 72.8, 56.4, 56.1, 42.6, 42.3, 40.2, 40.1, 36.9, 36.0, 
35.9, 35.6, 35.1, 34.6, 31.0, 30.2, 28.2, 27.3, 26.4, 26.0, 25.0, 24.9, 24.8, 24.7, 24.2, 23.4, 20.8, 
18.8, 18.7, 18.3, 12.6, 12.0, −4.6. 
IR (film): ʋ (cm-1) 2975, 2927, 2863, 1463, 1449, 1370, 1311, 1250, 1142, 1094, 1079, 968, 
870, 835, 774, 758, 668. 
HRMS (ESI) calcd. for C43H84B2NO5Si [M+NH4]
+ 744.6314, found 744.6330.  
[α]D26 = −15  (c 1, CHCl3). 
 
2,2'-((2S,3R,5S)-6-(methoxymethoxy)-3,5-dimethylhexane-1,2-diyl)bis(4,4,5,5-
tetramethyl-1,3,2-dioxaborolane) (8) 
Following GP4 with (2R,4S)-5-(methoxymethoxy)-2,4-
dimethylpentyl diisopropylcarbamate16 (0.33 mmol, 100 
mg), (–)-sparteine (0.36 mmol, 85 mg), and bis(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)methane (0.43 mmol, 
115 mg) gave 2,2'-((2S,3R,5S)-6-(methoxymethoxy)-3,5-
dimethylhexane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) as a colourless oil 
(61%, 111 mg, >20:1 dr). 
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1H NMR (400 MHz, CDCl3): 4.60 (s, 2H), 3.44 (dd, J 9.3, 4.7, 1H), 3.34 (s, 3H), 3.21 (dd, J 
9.3, 7.4, 1H), 1.71–1.78 (m, 2H), 1.38 (m, 1H), 1.23 (s, 12H), 1.22 (s, 12H), 1.13 (dt, J 11.9, 
4.4, 1H), 1.00–0.90 (m, 4H), 0.86 (d, J 6.8, 3H), 0.81 (m, 1H), 0.67 (dd, J 16.0, 4.6, 1H). 
13C NMR (100 MHz, CDCl3): 96.5, 82.8, 82.7, 73.2, 55.0, 39.3, 32.5, 31.1, 25.0, 24.9, 24.7, 
24.7, 18.6, 18.4, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2975, 2901, 1406, 1379, 1310, 1142, 1066, 1050, 892. 
HRMS (ESI) calcd. for C22H44B2NaO6 [M+Na]
+449.3224, found 449.3229.  
[α]D22 = +12  (c 1, CHCl3). 
 
2,2'-((2R,3R,5S)-6-(methoxymethoxy)-3,5-dimethylhexane-1,2-diyl)bis(4,4,5,5-
tetramethyl-1,3,2-dioxaborolane) (9) 
Following GP4 with (2R,4S)-5-(methoxymethoxy)-2,4-
dimethylpentyl diisopropylcarbamate16 (0.33 mmol, 100 mg), 
gave 9 as a colourless oil (69%, 126 mg, >20:1 dr). 
1H NMR (400 MHz, CDCl3): 4.59 (s, 2H), 3.44 (dd, J 9.3, 4.6, 1H), 3.34 (s, 3H), 3.19 (dd, J 
9.3, 7.5, 1H), 1.80 (m, 1H), 1.62 (m, 1H), 1.38 (m, 1H), 1.23–1.20 (m, 25H), 1.15 (dt, J 9.9, 
5.1, 1H), 1.01 (m, 1H), 0.93 (d, J 6.7, 3H), 0.89 (d, J 6.8, 3H), 0.70 (dd, J 15.7, 9.4, 1H). 
13C NMR (100 MHz, CDCl3): 96.4, 82.7, 82.7, 73.2, 55.0 (CH3), 40.5, 33.9, 30.9, 34.4, 24.9, 
24.8, 24.7, 24.1, 18.6, 18.2, carbons attached to boron not observed. 
IR (film): ʋ (cm-1) 2977, 2928, 2878, 1370, 1309, 1141, 1047, 968, 846. 
HRMS (ESI) calcd. for C22H44B2NaO6 [M+Na]
+449.3224, found 449.3231.  
[α]D22 = +3  (c 1, CHCl3). 
 
(R)-2,2'-(hex-5-yne-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (10) 
 Following a modified version of GP4 with benzoate 44 (0.25 mmol, 79 
mg), sBuLi (0.42 mL, 1.3 M in hexanes, 2.2 eq.) and (+)-sparteine (0.13 
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mL, 0.55 mmol, 2.2 eq.) gave 10 as a colourless oil (50%, 41 mg (corrected for small amount 
of diethyl ether in NMR sample), ≥95:5 er). Enantiomeric ratio determined after oxidation and 
formation of the corresponding dimethyl acetal. 
1H NMR (400 MHz, CHCl3): 2.19 (m, 2H), 1.90 (t, J 2.6, 1H), 1.72 (m, 1H), 1.56 (ddt, J 13.4, 
8.5, 6.8, 1H), 1.22 (app. s, 24H), 0.92–0.73 (m, 3H). 
13C NMR (101 MHz, CDCl3): 85.1, 82.9, 82.9, 67.8, 32.5, 24.9, 24.8, 24.8, 24.7, 17.7, carbons 
attached to boron not observed. 
IR (film): ʋ (cm-1) 3312, 2978, 2929, 2117, 1370, 1312, 1140, 968, 846, 626. 
HRMS (ESI) calcd. for C18H32B2NaO4 [M+Na]
+ 357.2385, found 357.2393.  
[α]D22 = −1  (c 1, CHCl3). 
Chiral GC: β-Dextrose column, 50 °C isocratic, 0.1 mL/min; tR: 39.01 min (minor), 39.06 min 
(major), er ≥95:5. 
       
 
General procedure for single homologation of diborylmethane (1) using secondary 
benzylic carbamates (GP5) 
To a vigorously stirred solution of secondary carbamate (1.5 eq.) and TMEDA (1.5 eq.) in 
anhydrous diethyl ether (0.33 M) at −78 °C under a nitrogen atmosphere, was added sBuLi (1.3 
M in hexane, 1.45 eq.) dropwise. After 15 min, a solution of bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)methane (1.0 eq.) in diethyl ether (0.5 M) was added dropwise. The reaction 
mixture was stirred at −78 °C for 1 h and then a 1.0 M solution of MgBr2 in anhydrous MeOH 
(1.7 eq.) was added slowly at 78 °C. After 5 min, the cooling bath was removed and stirring 
was continued at room temperature overnight (16 h). Afterwards the reaction mixture was 
diluted with water and extracted with Et2O. The combined organic phases were washed with 
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brine and dried over MgSO4. The solvent was removed in vacuo and the crude material purified 
by flash chromatography. 
(S)-2,2'-(2-Phenylpropane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (11) 
 
Following GP5 using carbamate 52 (6.77 mmol, 1.69 g) without TMEDA gave 
11 as a white solid (3.84 mmol, 1.43 g, 85%, 98:2 er). 
m.p. = 88–91 °C (EtOH) 
1H NMR (CDCl3, 400 MHz): 7.39 (2H, m), 7.25 (2H, m), 7.10 (1H, m), 1.49 (1H, d, J 15.7), 
1.41 (3H, s), 1.21 (6H, s), 1.21 (6H, s), 1.20 (6H, s), 1.18 (6H, s), 1.15 (1H, d, J 15.7). 
13C NMR (CDCl3, 101 MHz): 149.1, 127.9, 126.4, 124.8, 83.2, 82.9, 29.7, 25.1, 24.7, 24.5, 
24.4, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2981, 2928, 2872, 1471, 1379, 1353, 1313, 1137, 1111, 969, 837, 698.  
HRMS (ESI): calcd. for C21H34O2BNa [M+Na]
+ 395.2541, found 395.2535. 
Chiral HPLC: Chiralpak AS-H column with guard, 4% iPrOH in hexane, flow rate: 0.7 
mL/min, 20 °C; tR = 20.2 min (major), 26.2 min (minor). 98:2 er. 
 
Data were consistent with those previously reported.17 
(S)-2,2'-(2-((1,1'-biphenyl)-4-yl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2 
dioxaborolane)  (12) 
Following a modified version of GP4 with MTBE as solvent, without 
TMEDA and performing the reaction at −96 °C using carbamate 53 
(0.63 mmol, 205 mg, 98:2 er), 12 was obtained as a white solid (67%, 
126 mg, 95:5 er). 
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1H NMR (400 MHz, CDCl3): 7.60 (ap d, J 8.3, 2H), 7.51–7.53 (m, 2H), 7.46–7.48 (m, 2H), 
7.42 (ap t, J 7.6, 2H), 7.31 (ap t, J 7.6, 1H), 1.53 (d, J 15.7, 1H), 1.46 (s, 3H), 1.18–1.23 (m, 
25H). 
13C NMR (100 MHz, CDCl3): 148.4, 141.2, 137.5, 128.6, 126.9, 126.9, 126.7, 126.5, 83.3, 
83.0, 25.1, 24.7, 24.7, 24.5, 24.4, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2977, 2928, 1487, 1466, 1358, 1347, 1311, 1143 
HRMS (ESI) calcd. for C27H38B2NaO4 [M+Na]
+ 471.2858, found 471.2846.  
[α]D22 = −22 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 40°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 
11.87 min (minor), 17.54 min (major), er 95:5.  
 
 
 
  
(S)-2,2'-(2-(4-chlorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (13) 
Following GP5 with carbamate 54 (0.63 mmol, 179 mg, 99:1 er) and 
no TMEDA gave 13 as a white solid (73%, 125 mg, 98:2 er). 
1H NMR (400 MHz, CDCl3): 7.31 (ap d, J 8.6, 2H), 7.21 (ap d, J 8.6, 
2H), 1.42 (d, J 15.6, 1H), 1.37 (s, 3H), 1.17–1.24 (m, 24H), 1.11 (d, J 15.6, 1H). 
13C NMR (100 MHz, CDCl3): 147.7, 130.5, 127.9, 127.8, 83.4, 83.0, 27.0, 25.0, 24.7, 24.6, 
24.5, 24.4, 22.1. 
IR (film): ʋ (cm-1) 2978, 2928, 1490, 1471, 1379, 1342, 1313, 1136, 1008, 968, 838, 713. 
HRMS (ESI) calcd. for C21H34B2ClO4 [M+H]
+, 407.2334, found 407.2329 
[α]D22 = −6 (c 1, CHCl3). 
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Chiral SFC: Whelk-01, 125 bar, 40°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 4.40 
min (minor), 6.12 min (major), er 98:2. 
 
(S)-2,2'-(2-(p-tolyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (14) 
Following GP5 with carbamate 55 (0.63 mmol, 166 mg, 99:1 er) gave 
14 as an amorphous white solid (68%, 110 mg, 98:2 er). 
1H NMR (300 MHz, CDCl3): 7.28 (d, J 8.2, 2H), 7.07 (d, J 8.2, 2H), 
2.30 (s, 3H), 1.48 (d, J 15.6, 1H), 1.36 (s, 3H), 1.23 (s, 12H), 1.21 (s, 6H), 1.19 (s, 6H), 1.11 
(d, J 15.6, 1H). 
13C NMR (76 MHz, CDCl3): 146.3, 134.1, 128.7, 126.4, 83.3, 83.0, 26.8, 25.2, 24.9, 24.8, 
24.6, 24.5, 22.0, 20.9. 
IR (film): ʋ (cm-1) 2977, 2927, 1511, 1462, 1348, 1308, 1142, 969, 845, 672.  
HRMS (CI): calcd. for C22H36B2NaO4 [M+Na]
+ 409.2700, found 409.2713.  
[α]D22 = −13 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 42°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 3.65 
min (minor), 4.78 min (major), er 98:2.  
 
 
 
 
 
S23 
 
 
(S)-2,2'-(2-(4-methoxyphenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (15) 
Following GP5 with carbamate 56 (0.63 mmol, 176 mg, >99:1 er) 
gave 15 as a white solid (81%, 137 mg, 98:2 er). 
1H NMR (400 MHz, CDCl3): 7.30 (app. d, J 8.8, 2H), 6.81 (app. d, 
J 8.8, 2H), 3.77 (s, 3H), 1.45 (d, J 15.5, 1H), 1.37 (s, 3H), 1.21 (s, 12H), 1.19 (s, 6H), 1.18 (s, 
6H), 1.10 (d, J 15.5, 1H). 
13C NMR (100 MHz, CDCl3): 156.9, 141.3, 127.3, 113.2, 83.2, 82.9, 55.1, 25.1, 24.9, 24.7, 
24.5, 24.4, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2977, 2931, 1614, 1510, 1378, 1349, 1308, 1247, 1142. 
HRMS (ESI) calcd. for C22H36B2NaO5 [M+Na]
+ 425.2649, found 425.2646.  
[α]D22 = −9 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 42°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 6.02 
min (minor), 8.72 min (major), er 98:2.  
 
 
 
 
  
(S)-2,2'-(2-(4-fluorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (16) 
Following GP5 with carbamate 57 (0.63 mmol, 168 mg, >99:1 er) and 
no TMEDA gave 16 as a white solid (75%, 123 mg, >99:1 er). 
1H NMR (400 MHz, CDCl3): 7.33 (app. dd, J 8.8, 5.6, 2H), 6.93 (app. 
t, J 8.8, 2H), 1.45 (d, J 15.6, 1H), 1.38 (s, 3H), 1.19 (s, 18H), 1.17 (s, 6H), 1.13 (d, J 15.6, 1H). 
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13C NMR (100 MHz, CDCl3): 159.6 (d, 
1JC-F 242.4), 143.7, 126.9 (d, 
3JC-F 7.6), 113.4 (d, 
2JC-
F 20.7), 82.3, 82.0, 24.0, 23.8, 23.7, 23.5, 23.4 carbons attached to boron not observed. 
19F NMR (376 MHz; CDCl3): 119.5 (m) 
IR (film): ʋ (cm-1) 2978, 2931, 1605, 1508, 1371, 1314, 1143, 968, 846. 
HRMS (ESI) calcd. for C21H34B2FO4 [M+H]
+ 391.2629, found 391.2632.  
[α]D22 = −6  (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 40°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 3.02 
min (major), 3.68 min (minor), er > 99:1.  
 
 
 
  
(S)-2,2'-(2-(2-fluorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (17) 
Following GP5 with carbamate 58 (0.63 mmol, 168 mg, 99:1 er) and no 
TMEDA gave 17 as a white solid (46%, 75 mg, 99:1 er). 
1H NMR (400 MHz, CDCl3): 7.34 (ap td, J 7.9, 1.9, 1H), 7.03–7.13 (m, 
2H), 6.94 (m, 1H), 1.42 (s, 3H), 1.29–1.26 (m, 2H), 1.24 (s, 12H), 1.17 (bs, 6H), 1.15 (s, 6H).  
13C NMR (100 MHz, CDCl3): 161.1 (d, 
1JC-F 243.9), 136.6 (d, 
2JC-F 14.1), 127.1 (d, JC-F 5.4), 
126.6 (d, JC-F 8.6), 123.8 (d, JC-F 3.2), 114.8 (d, JC-F 23.1), 83.4, 82.8, 24.9, 24.7, 24.7, 24.6, 
23.2, carbons attached to boron not observed. 
IR (film): ʋ (cm-1) 2977, 2931, 1449, 1371, 1352, 1144, 968, 845, 754 
19F NMR (376 MHz; CDCl3): 112.0 (dt, J 11.4, 5.6) 
HRMS (ESI) calcd. for C21H33B2FNaO4 [M+Na]
+ 413.2449, found 413.2451.  
[α]D22 = −11  (c 1, CHCl3). 
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Chiral SFC: Chiralcel IA , 125 bar, 42°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 
5.73 min (major), 8.00 min (minor), er 99:1. 
 
 
 
 
(S)-2,2'-(2-(2-methoxyphenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (18) 
Following GP5 with carbamate 59 (0.63 mmol, 176 mg, >99:1 er) gave 18 
as a white solid (45%, 76 mg, >99:1 er). 
1H NMR (400 MHz, CDCl3): 7.29 (dd, J 7.7, 1.6, 1H), 7.11 (m, 1H), 6.89 
(m, 1H), 6.77 (dd, J 8.1, 1.2, 1H), 3.79 (s, 3H), 1.41 (s, 3H), 1.29 (d, J 14.7, 1H), 1.24–1.18 (s, 
13H), 1.16 (s, 6H), 1.13 (s, 6H). 
13C NMR (100 MHz, CDCl3): 156.6, 138.0, 126.1, 125.9, 120.5, 109.6, 82.8, 82.5, 54.8, 24.9, 
24.8, 24.8, 24.7, 22.6, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2976, 2931, 1607, 1615, 1488, 1463, 1347, 1323, 1239, 1144. 
HRMS (ESI) calcd. for C22H37B2O5 [M+H]
+ 403.2830, found 403.2844.  
[α]D22 = −27 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 40°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 4.37 
min (minor), 5.41 min (major), er >99:1.  
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Homologation of a dialkyl carbenoid 
(R)-2,2'-(2-methyl-4-phenylbutane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(20) 
nBuLi (0.18 mL, 0.28 mmol, 1.1 eq.) was added dropwise to a solution 
of  (S)-4-phenyl-2-(trimethylstannyl)butan-2-yl 2,4,6-
triisopropylbenzoate (19)18 (135 mg, 0.25 mmol, 1 eq.) and TMEDA 
(0.04 mL, 0.28 mmol, 1.1 eq.) in Et2O (1 mL) at –78 °C. After 2 h at this temperature an 
ethereal solution of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (101 mg, 1.5 
mmol, 1.5 eq.) was added. After 2 h the reaction mixture was warmed to room temperature 
then heated at reflux overnight. The reaction mixture was quenched through addition of water 
(5 mL) and the organic layer separated. The aqueous phase was washed with Et2O (2 × 5 mL), 
the organics were combined, dried over MgSO4, filtered and concentrated in vacuo. 
Purification of the residue by column chromatography gave 20 (62 mg, 62%). 
1H NMR (400 MHz, CDCl3): 7.26 (m, 2H), 7.19–7.11 (m, 3H), 2.56 (m, 2H), 1.63 (m, 2H), 
1.27 (s, 12H), 1.24 (s, 12H), 1.06 (s, 3H), 1.04 (d, J 10.6, 1H), 0.77 (d, J 15.6, 1H). 
13C NMR (100 MHz, CDCl3): 143.8, 128.4, 128.2, 125.3, 83.0, 82.8, 44.2, 32.4, 25.0, 24.9, 
24.8, 24.7, 23.9, carbons attached to boron not observed. 
IR (film): ʋ (cm-1) 2977, 2928, 2862, 1470, 1370, 1309, 1143, 969, 846, 698. 
HRMS (ESI) calcd. for C23H38B2NaO4 [M+Na]
+ 423.2857, found 423.2869.  
[α]D22 = −3 (c 1, CHCl3). 
Chiral HPLC (Chiralpak IB, 90:10 hexane:IPA, 1 ml/min, RT) tR: 10.18 min (major), 14.99 
min (minor), er 95:5  
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General Procedure for Symmetrical Double Homologation of Diborylmethane (GP6) 
nBuLi (0.25 mL, 0.40 mmol, 2.00 eq., 1.6 M in hexanes) was added dropwise to a solution of 
stannane (0.41 mmol, 2.05 eq.) in Et2O (2.05 mL) at −78 °C. After 1 h at this temperature a 
solution of bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (0.2 mmol, 1.0 eq.) in 
diethyl ether (0.4 mL) was added dropwise. The reaction mixture was warmed to RT after 2 h 
and then stirred overnight. The reaction mixture was quenched with water (10 mL) and the 
organic layer separated. The aqueous phase was washed with Et2O (3 x 10 mL), the organics 
were combined, dried (MgSO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (3–10% Et2O/pentane) afford C2-symmetric 1,3-bis(boronic ester). 
 
2,2'-((3S,5S)-1,7-bis(4-methoxyphenyl)heptane-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (4) 
Following modified version of GP6 using 
stannane 46 (185 mg, 0.27 mmol, 1.1 eq.), 
nBuLi (0.16 mL, 0.25 mmol, 1 eq.) and 
diborylmethane 1 (100 mg, 0.37 mmol, 1.5 eq.) gave 1,3-bis(boronic ester) 4 (92 %, 65 mg). 
1H NMR (400 MHz, CDCl3): 7.11–7.04 (m, 4H), 6.82–6.77 (m, 4H), 3.77 (s, 6H), 2.65–2.43 
(m, 4H), 1.70–1.57 (m, 4H), 1.52 (t, J 8.0, 2H), 1.24–1.21 (m, 24H), 1.05 (m, 2H). 
13C NMR(100 MHz, CDCl3): 155.6, 133.3, 127.4, 111.7, 80.9, 53.3, 32.7, 32.4, 31.1, 22.9 
(overlapping peaks), carbons attached to boron not observed. 
IR (film): ʋ (cm-1) 2981, 2928, 2855, 1612, 1586, 1511, 1379, 1370, 1241, 1141, 1040, 824. 
HRMS (ESI) calcd. for C33H50B2NaO6 [M+Na]
+ 587.3697, found 587.3686.  
[α]D22 = −8  (c 1, CHCl3). 
 
2,2'-((2S,4S)-pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (21) 
According to GP6 using stannane ent-47 (180 mg, 0.41 mmol) gave 1,3-
bis(boronic ester) 21 (71%, 46 mg) 
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1H NMR (300 MHz, CDCl3): 1.41 (t, J 7.7, 2H), 1.22 (s, 24H), 1.06 (sextet, J 7.4, 2H), 0.92 
(d, J 7.2, 2H). 
13C NMR (100 MHz, CDCl3): 82.7, 36.0, 24.7, 15.4 carbon attached to boron not observed.  
IR (film): ʋ (cm-1) 2978, 2951, 2931, 2871, 1460, 1379, 1370, 1310, 1142, 968, 861, 685. 
HRMS (ESI) calcd. for C17H34B2NaO4 [M+Na]
+ 347.2542, found 347.2549.  
[α]D22 = +13 (c 2, CHCl3). 
 
2,2'-((3R,5R)-2,6-dimethylheptane-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(22) 
According to GP6 using stannane 51 (192 mg, 0.41 mmol) gave 1,3-
bis(boronic ester) 22 (88%, 68 mg). 
1H NMR (400 MHz, CDCl3): 1.68 (app. octet, J 6.7, 1H), 1.47 (dd, J 9.1, 6.6, 2H), 1.24 (s, 
12H), 1.23 (s, 12H), 0.92 (d, J 6.3, 6H), 0.91 (d, J 6.5, 6H), 0.76 (dt, J 8.8, 6.3, 2H). 
13C NMR (100 MHz, CDCl3): 80.8, 28.6, 26.7, 23.2, 23.2, 22.9, 22.9, 20.5, 19.8. 
IR (film): ʋ (cm-1) 2977, 2955, 2935, 1470, 1378, 1371, 1307, 1143, 973. 
HRMS (ESI) calcd. for C21H42B2NaO4 [M+Na]
+ 403.3169, found 403.3168.  
[α]D22 = +19 (c 1, CHCl3). 
 
2,2'-((5S,7S)-undeca-1,10-diene-5,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) 
(23) 
According to GP6 using stannane 50 (197 mg, 0.41 mmol) gave 
1,3-bis(boronic ester) 23 (64%, 52 mg). 
1H NMR (400 MHz, CDCl3): 5.80 (ddt, J 16.9, 10.2, 6.6, 2H), 4.98 (dq, J 17.1, 1.8, 2H), 4.90 
(ddt, J 10.2, 2.3, 1.2, 2H), 2.10–1.96 (m, 4H), 1.52–1.36 (m, 4H), 1.24–1.21 (s, 24H), 1.01 
(app. p, J 7.9, 2H). 
13C NMR (100 MHz, CDCl3): 139.3, 114.1, 82.8, 33.4, 32.9, 31.3, 24.8, 24.8. 
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IR (film): ʋ (cm-1) 2978, 2922, 2852, 1646, 1379, 1371, 1312, 1142, 967, 907. 
HRMS (ESI) calcd. for C23H42B2NaO4 [M+Na]
+ 427.3170, found 427.3166.  
[α]D22 = +5 (c 1, CHCl3). 
 
(6R,8R)-2,2,12,12-tetramethyl-6,8-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,11-
dioxa-2,12-disilatridecane  (24) 
        According to GP6 using stannane 49 (150 mg, 0.26 mmol) 
gave 1,3-bis(boronic ester) 24 (55 %, 42.1 mg). 
1H NMR (400 MHz, CDCl3):  3.63  3.51 (m, 4H), 1.62  1.56 (m, 4H), 1.47  1.43 (m, 2H), 
1.22 (s, 24H), 1.02  0.98 (m, 2H) 0.88 (s, 18H), 0.03 (s, 12H)  
13C NMR (101 MHz, CDCl3):  82.8, 63.2, 35.0, 33.0, 26.0, 24.8, 18.4, −5.2 carbon attached 
to boron not observed.      
[α]D22 =  2 (c = 1.0, CHCl3) 
IR (film): ʋ (cm-1) 2928, 2857, 1463, 1371, 1311, 1251, 1142, 1092, 834. 
HRMS (ESI) calc. C31H66B2NaO6Si2[M+Na]
+ 635.4488, found 635.4466. 
 
2,2'-((2S,4S)-2,4-bis(4-methoxyphenyl)pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (25) 
Carbamate 56 (112 mg, 0.4 mmol, 2.0 eq., >99:1 er) and TMEDA 
(2.0 eq.) were dissolved in anhydrous TBME (0.33 M) and cooled 
to −78 °C. sBuLi (1.3 M in hexane, 2.2 eq.) was added dropwise 
and after 15 min, a solution of 15 (80 mg, 0.2 mmol, 1.0 eq., 98:2 
er) in TBME (0.5 M) was added dropwise. The reaction mixture 
was stirred at −78 °C for 1 h and then stirred overnight at room temperature. The reaction 
mixture was then diluted with water and extracted with Et2O. The combined organic phases 
were washed with brine and dried over MgSO4. The solvent was removed in vacuo and the 
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crude material purified by flash chromatography affording to 25 (32 %, 34 mg, >20:1 dr) as a 
white solid. 
1H NMR (400 MHz, CDCl3): 7.36 (app. d, J 8.7, 4H), 6.80 (app. d, J 8.7, 4H), 3.77 (s, 6H), 
2.34 (s, 2H), 1.43 (s, 6H), 1.10 (s, 12H), 1.06 (s, 12H). 
13C NMR (100 MHz, CDCl3): 157.0, 140.0, 127.8, 113.2, 83.3, 55.2, 47.9, 24.7, 24.3, 20.5, 
carbon attached to boron not observed.  
IR (film): ʋ (cm-1) 2973, 2903, 1509, 1467, 1379, 1307, 1248, 1186, 1129, 1057, 840. 
HRMS (ESI) calcd. for C31H46B2NaO6 [M+Na]
+ 559.3383, found 559.3369.  
[α]D22 = −2 (c 1, CHCl3). 
 
2,2'-((2S,4R)-2-(4-methoxyphenyl)pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (26) 
Stannane ent-47 (79 mg, 0.18 mmol, 1.0 eq.) was dissolved in 
anhydrous Et2O (0.2 M) under an atmosphere of nitrogen in the 
receiving section of the Fawcett Flask.19 The reaction mixture was 
cooled to –78 °C and nBuLi (1.6 M in hexanes, 1.0 eq.) was added 
dropwise. After 1 h at –78 °C 15 (80 mg, 0.2 mmol, 98:2 er, 0.5 M in anhydrous Et2O, 1.1 eq.) 
was tipped from the delivering side of the Fawcett Flask to the solution of carbenoid and the 
resulting mixture was stirred at –78 °C for 30 min. The reaction mixture was stirred for a further 
4 h at room temperature and was then diluted with water and extracted with Et2O. The 
combined organic phases were washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the crude material purified by flash chromatography to afford 26 (59 %, 
46 mg, >20:1 dr) as a white solid. 
1H NMR (400 MHz, CDCl3): 7.22 (app. d, J 8.8, 2H), 6.79 (app. d, J 8.8, 2H), 3.76 (s, 3H), 
2.01 (dd, J 13.8, 8.0, 1H), 1.79 (dd, J 13.8, 3.6, 1H), 1.30 (s, 3H), 1.19 (s, 12H), 1.17 (s, 6H), 
1.16 (s, 6H), 0.85 (d, J 7.2, 3H), 0.77 (m, 1H). 
13C NMR (100 MHz, CDCl3): 156.9, 138.3, 128.1, 113.3, 83.0, 82.6, 55.1, 42.0, 24.7, 24.6, 
24.6, 24.5, 21.4, 17.8, carbons attached to boron not observed.  
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IR (film): ʋ (cm-1) 2976, 2901, 1510, 1406, 1380, 1308, 1249, 1145, 1066, 1057. 
HRMS (ESI) calcd. for C24H40B2NaO5 [M+Na]
+ 453.2963, found 453.2952.  
[α]D22 = −12 (c 1, CHCl3). 
 
2,2'-((2R,3S,5R)-3-(4-methoxyphenyl)-3-methylhexane-2,5-diyl)bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolane) (27) 
Stannane ent-47 (194 mg, 0.44 mmol, 2.2 eq.) was dissolved in 
anhydrous Et2O (0.2 M) under an atmosphere of nitrogen. The 
reaction mixture was cooled to –78 °C and nBuLi (1.6 M in hexanes, 
2.1 eq.) was added dropwise. After 1 h, 15 (80 mg, 0.2 mmol, 98:2 er, 0.5 M in anhydrous Et2O, 
1.0 eq.) was added dropwise to the reaction mixture at –78 °C. The reaction mixture was stirred 
at – 78 °C for 30 min, then was removed from the cooling bath and stirred at room temperature 
for 4 h. The reaction mixture was diluted with water and extracted with Et2O. The combined 
organic phases were washed with brine and dried over MgSO4. The solvent was removed in 
vacuo and the crude material purified by flash chromatography to afford 27 (52 %, 48 mg, 
>20:1 dr). 
1H NMR (400 MHz, CDCl3): 7.18 (app. d, J 8.8, 2H), 6.98 (app. d, J 8.8, 2H), 3.77 (s, 3H), 
2.02 (dd, J 13.5, 8.8, 1H), 1.67 (dd, J 13.5, 2.6, 1H), 1.42 (q, J 7.4, 1H), 1.28 (s, 6H), 1.28 (s, 
6H), 1.26 (s, 3H, partially overlapped with q, 1H), 1.19 (s, 6H), 1.18 (s, 6H), 0.71 (d, J 7.5, 
3H), 0.58 (d, J 7.4, 3H).  
13C NMR (100 MHz, CDCl3): 157.0, 139.9, 127.7, 112.9, 82.8, 82.6, 55.1, 47.4, 43.2, 24.9, 
24.8, 24.7, 24.6, 19.9, 17.8, 11.0, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2976, 2930, 1512, 1379, 1313, 1249, 1146, 1042. 
HRMS (ESI) calcd. for C26H44B2NaO5 [M+Na]
+ 481.3276, found 481.3295.  
[α]D22 = −16 (c 1, CHCl3). 
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General Procedure for Mixed Double Homologation of Diborylmethane 1 (GP7) 
sBuLi (0.23 mL, 0.3 mmol, 1 eq.) was added dropwise to a solution of 3-(4-
methoxyphenyl)propyl N,N-diisopropylcarbamate8 (28, 88 mg, 0.3 mmol, 1 eq.) and (+)-
sparteine (0.07 ml, 0.3 mmol, 1 eq.) in Et2O (1.5 mL) at −78 °C. After 3 h a solution of 
bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methane (80 mg, 0.3 mmol, 1 eq.) in Et2O (0.3 
mL) was added dropwise and stirred for 2 h at −78 °C. A solution of stannane (0.45 mmol, 1.5 
eq.) in Et2O (2.25 mL) was added dropwise, followed by slow addition (~1 drop / 20 seconds) 
of nBuLi (0.26 mL, 1.6 M in hexanes, 1.45 eq.) and the reaction mixture stirred for 1 h at −78 
°C. The reaction mixture was warmed to room temperature, heated at reflux overnight and 
quenched through addition of water. The organic layer was separated and the aqueous layer 
washed with Et2O. The organics were combined, dried over MgSO4, filtered and concentrated 
in vacuo. Purification of the residue by column chromatography (SiO2) eluting with 10% Et2O 
in pentane gave 1,3-bis(boronic ester). 
2,2'-((2S,4S)-6-(4-methoxyphenyl)hexane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (31) 
Following GP7 using stannane ent-47 (198 mg) gave 1,3-
bis(boronic ester) 31 (60%, 80 mg). 
1H NMR (400 MHz, CDCl3): 7.10 (app. d, J 8.6, 2H), 6.81 (app. d, J 8.6, 2H), 3.78 (s, 3H), 
2.63–2.45 (m, 2H), 1.73–1.59 (m, 2H), 1.55 (ddd, J 13.1, 8.8, 6.7, 1H), 1.38 (m, 1H), 1.26 (s, 
12H), 1.22 (s, 6H), 1.21 (s, 6H), 1.12–1.00 (m, 2H), 0.95 (d, J 7.2, 3H). 
13C NMR (100 MHz, CDCl3): 157.5, 135.3, 129.2, 113.6, 82.8, 82.7, 55.2, 34.7, 34.6, 34.0, 
24.9 (×2), 24.8 (×2), 24.7 (×4), 16.0, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2977, 2928, 1512, 1380, 1371, 1314, 1246, 1143, 1039, 862. 
HRMS (ESI) calcd. for C25H42B2NaO5 [M+Na]
+ 467.3119, found 467.3124.   
[α]D22 = −2 (c 1, CHCl3). 
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2,2'-((3S,5S)-1-(4-methoxyphenyl)-7-phenylheptane-3,5-diyl)bis(4,4,5,5-tetramethyl-
1,3,2-dioxaborolane) (32) 
Following GP7 using stannane 48 (239 mg) gave 1,3-
bis(boronic ester) 32 (53%, 84 mg). 
1H NMR (400 MHz, CDCl3): 7.28–7.21 (m, 2H), 7.19–
7.13 (m, 3H), 7.11 – 7.06 (m, 2H), 6.83–6.77 (m, 2H), 3.77 (s, 3H), 2.68–2.45 (m, 4H), 1.77–
1.57 (m, 4H), 1.53 (app. t, J 8.0, 2H), 1.24–1.22 (s, 24H), 1.12–0.99 (m, 2H). 
13C NMR (100 MHz, CDCl3): 157.5, 143.1, 135.3, 129.3, 128.4, 128.1, 125.4, 113.6, 82.8, 
82.8, 55.2, 35.6, 34.6, 34.3, 34.1, 33.0 , 24.8 (×4) carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2977, 2924, 2862, 1612, 1589, 1512, 1379, 1371, 1314, 1245, 1142, 699. 
HRMS (ESI) calcd. for C32H48B2NaO5 [M+Na]
+ 557.3591, found 557.3583.  
[α]D21  = −7 (c 1, CHCl3). 
 
tert-butyl(((3R,5S)-7-(4-methoxyphenyl)-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)heptyl)oxy)dimethylsilane (33) 
Using GP7 and stannane 49 (0.263 g, 0.45 mmol) gave 
1,3-bis(boronic ester) 33 (0.043 g, 24 %). 
 
1H NMR (400 MHz, CDCl3): 7.09 (d, J 8.5, 2H), 6.79 (d, J 8.5, 2H), 3.77 (s, 3H), 3.58 (m, 
2H), 2.57 – 2.49 (m, 2H), 1.64 – 1.56 (m, 4H), 1.48 (t, J 8, 2H), 1.24 (s, 12H), 1.2 (s, 12H), 
1.10-0.95 (m, 2H), 0.88 (s, 9H), 0.03 (s, 6H). 
13C NMR (101 MHz, CDCl3): 157.5, 135.3, 130.0, 113.6, 82.8, 82.7, 63.2, 55.2, 35.2, 34.6, 
34.3, 33.1, 26.0, 24.9, 24.8, 18.4, −5.2, carbons attached to boron not observed.  
[α]D22 =  5 (c = 1.0, CHCl3) 
IR (film): ʋ (cm-1) 2977, 2928, 2856, 1371, 1312. 
HRMS (ESI) calc. C32H58B2NaO6Si [M+Na]
+ 611.4093, found 611.4080. 
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2,2'-((3S,5S)-1-(4-methoxyphenyl)non-8-ene-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (34) 
Following GP7 using stannane 50 (216 mg) gave 1,3-
bis(boronic ester) 34 (74 mg, 51%) 
 
1H NMR (400 MHz, CDCl3): 7.09 (m, 2H), 6.79 (m, 2H), 5.80 (ddt, J 16.9, 10.1, 6.7, 1H), 
4.98 (app. dq, J 17.1, 1.7, 1H), 4.90 (ddt, J 10.1, 2.2, 1.2, 1H), 3.77 (s, 3H), 2.53 (m, 2H), 2.04 
(m, 2H), 1.72–1.54 (m, 3H), 1.53–1.35 (m, 3H), 1.26–1.23 (s, 12H), 1.21–1.19 (s, 12H), 1.10–
0.96 (m, 2H). 
13C NMR (100 MHz, CDCl3): 157.5, 139.3, 135.3, 129.3, 114.1, 113.6, 82.8, 82.8, 55.3, 34.6, 
34.4, 33.4, 33.0, 31.3, 24.9, 24.8, carbons attached to boron not observed.  
IR (film): ʋ (cm-1) 2977, 2922, 2858, 16423, 1615, 1586, 1512, 1379, 1314, 1245, 1142, 1039, 
967, 862. 
HRMS (ESI) calcd. for C28H46B2O5Na [M+Na]
+ 507.3433, found 507.3414.  
[α]D21 = −3 (c 1, CHCl3). 
 
2,2'-((2R,4S)-6-(4-methoxyphenyl)hexane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (35) 
Following GP7 using stannane 47 (198 mg) gave 1,3-
bis(boronic ester) 35 (57%, 77 mg). 
1H NMR (400 MHz, CDCl3): 7.09 (d, J 8.6, 2H), 6.80 (d, J 
8.6, 2H), 3.77 (s, 3H), 2.64–2.41 (m, 2H), 1.75–1.55 (m, 3H), 1.36 (ddd, J 13.6, 8.6, 6.8, 1H), 
1.25 (s, 12H), 1.20 (s, 12H), 1.16 (m, 1H), 1.07 (m, 1H), 0.95 (d, J 7.3, 3H). 
13C NMR (100 MHz, CDCl3): 157.5, 135.3, 129.2, 113.6, 82.8, 82.7, 55.3, 34.7, 33.7, 33.6, 
24.9, 24.8, 24.7, 24.7, 15.2. 
IR (film): ʋ (cm-1) 2977, 2931, 2858, 1512, 1379, 1370, 1313, 1245, 1143, 1038. 
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HRMS (ESI) calcd. for C25H42B2NaO5 [M+Na]
+ 467.3119, found 467.3101.  
[α]D22 = −1 (c 1, CHCl3). 
 
C-B Functionalisation Reactions  
(R)-2,2'-(2-(4-methoxyphenyl)-2-methylbutane-1,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-
dioxaborolane) (36) 
A solution of 1,2-bis(boronic ester) 15 (80 mg, 0.2 mmol, 1.0 
equiv) and bromochloromethane (155 mg, 78 µL, 1.2 mmol, 
6.0 equiv) was dissolved in anhydrous Et2O (0.2 M) under an 
atmosphere of nitrogen. The reaction mixture was cooled to –
78 °C. nBuLi (1.6 M in hexanes, 5 equiv) was added dropwise 
to the reaction mixture at –78 °C. The reaction mixture was stirred for 20 min at –78 °C. The 
reaction mixture was removed from the cooling bath and stirred at room temperature for 1 h. 
Afterwards, the reaction mixture was diluted with water and extracted with Et2O (3 ×). The 
combined organic phases were washed with brine and dried over MgSO4. The solvent was 
removed in vacuo and the crude material purified by flash chromatography to afford double 
homologation product 36 (83%, 71 mg). 
Rf = 0.16 (Pentane/diethyl ether 8:1). 
1H NMR  (400 MHz, CDCl3): 7.22 (ap d, J 8.8, 2H), 6.78 (ap d, J 8.8, 2H), 3.76 (s, 3H), 1.75 
(ddd, J 13.8, 12.0, 5.3, 1H), 1.67 (ddd, J 13.8, 12.0, 5.4, 1H), 1.38 (s, 3H), 1.24–1.32 (2H, m), 
1.19 (s, 12H), 1.06 (s, 6H), 1.04 (s, 6H), 0.55 (ddd, J 15.7, 12.0, 5.4, 1H), 0.45 (ddd, J 15.7, 
12.0, 5.3, 1H). 
13C NMR (100 MHz, CDCl3): 157.1, 141.4, 127.4, 113.0, 82.7, 82.6, 55.2, 40.1, 39.5, 26.0, 
24.8, 24.7, 24.6, 24.4, carbons attached to boron not observed.  
11B NMR  (128 MHz; CDCl3): 33.1 
IR (film): ʋ (cm-1) 2977, 2930, 1610, 1513, 1356, 1318, 1249, 1145, 1037, 969, 848, 830,  
HRMS (ESI) calcd. for C24H40B2NaO5 [M+Na]
+ 453.2963, found 453.2963.  
[α]D26 = +15 (c 1, CHCl3). 
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(S)-1-methoxy-4-(3-methylhexa-1,5-dien-3-yl)benzene (37) 
To stirred neat tetravinyltin (36 µl, 0.2 mmol) under an atmosphere of nitrogen 
at ambient temperature, was added n-BuLi (1.6 M in hexane, 0.5 ml, 0.8 mmol) 
dropwise and stirred for 30 min. Then the precipitate was washed with  
anhydrous hexane (~0.5 ml ×3). Anhydrous THF (0.5 mL) was added to dissolve 
the precipitate and the resulting homogenous solution was taken up into a syringe and was added 
dropwise to a stirred solution of boronic ester 15 (80 mg, 0.2 mmol) in anhydrous Et2O (1 ml) under an 
atmosphere of nitrogen at −78 °C. The reaction mixture was stirred for 45 min at −78°C, then was 
warmed at ambient temperature and stirred for 20 min. The reaction mixture was cooled to −78 °C and 
a solution of iodine (203 mg, 0.8 mmol) in anhydrous THF (0.8 ml) was added dropwise. The reaction 
mixture was stirred at −78 °C for 30 min and then a suspension of NaOMe (86 mg, 1.6 mmol) in MeOH 
(2 ml) was added dropwise. The reaction mixture was stirred for 30 min at −78 °C and then allowed to 
reach ambient temperature and stirred for approximately 2 h. Sat. aq. Na2S2O3 (5 ml) and water (2 ml) 
was added and the mixture stirred until the brown colour dissipated. The mixture was extracted with 
diethyl ether (3 × 10 ml), washed with aq. NaOH (5 mL, 1M solution), KF (5 mL) and brine. The 
organic phase was dried over MgSO4 and the solvent was removed in vacuo to give 37 (77%, 32 mg) 
as a colourless oil. 
Rf = 0.6 (Pentane/diethyl ether 20:1).  
1H NMR (400 MHz, CDCl3): 7.24 (ap d, J 8.5, 2H), 6.85 (ap d, J 8.5, 2H), 6.02 (dd J 17.5, 
10.7, 1H), 5.61 (ddt, J 17.3, 10.2, 7.4, 1H), 5.09 (dd, J 10.7, 1.3, 1H), 5.03 (dd, J 17.5, 1.3, 
1H), 4.97–5.04 (m, 2H), 3.80 (s, 3H), 2.45–2.56 (m, 2H), 1.34 (s, 3H). 
13C NMR (100 MHz, CDCl3): 157.6, 146.8, 139.0, 135.2, 127.7, 117.1, 113.4, 111.7, 55.2, 
45.6, 43.4, 25.0. 
IR (film): ʋ (cm−1) 2972, 2901, 1625, 1597, 1512, 1410, 1249, 1183, 1066, 1038, 913, 828. 
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(S)-2-(4-methoxyphenyl)propane-1,2-diol (38) 
A premixed solution of 2M aq. NaOH/30% aq. H2O2 (2:1, 3 mL) was 
added dropwise to a solution of boronic ester 15 (80 mg, 0.2 mmol, 
98:2 er) in THF (2 mL) at 0 °C. The reaction mixture was warmed to 
room temperature and stirred at this temperature for 4 h. The reaction 
mixture was diluted with H2O (2 mL) and Et2O (2 mL). The phases were separated and the 
aqueous phase washed with Et2O (3 × 2 mL). The combined organic phases were washed with 
H2O (5 mL), dried (MgSO4) and concentrated under reduced pressure. Purification by flash 
chromatography gave diol 38 (98%, 36 mg, 98:2 er). 
Rf = 0.29 (Ethyl acetate/Pentane 4:1).  
1H NMR (400 MHz, CDCl3): 7.37 (ap d, J 8.8, 2H), 6.89 (ap d, J 8.8, 2H), 3.80 (s, 3H), 3.75 
(d, J 11.1, 1H), 3.59 (d, J 11.1, 1H), 2.10 (bs, 2H), 1.51 (s, 3H). 
13C NMR (100 MHz, CDCl3): 158.7, 137.0, 126.3, 113.7, 74.5, 71.1, 55.3, 26.0.  
IR (film): ʋ (cm−1) 3392, 2933, 1611, 1512, 1301, 1247, 1179, 1031, 831. 
HRMS (ESI) calcd. for C10H14NaO3 [M+Na]
+ 205.0835, found 205.0835.  
[α]D26 = +6 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 42°C, 4 mL/min, 10% co-solvent (50% IPA/Hexane); tR: 6.02 
min (minor), 8.72 min (major), er 98:2.  
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(S)-2-(2-(4-methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (39) 
Boronic ester 15 (80 mg, 0.2 mmol, 1.0 equiv, 98:2 er) and tetra-
n-butylammonium fluoride trihydrate (189 mg, 0.6 mmol, 3 
equiv) were stirred in toluene at 90 °C for 2 h. Afterwards the 
mixture was filtered through a short silica column, concentrated 
in vacuo and the residue subjected to flash chromatography to afford primary boronic ester 39 
(72%, 40 mg, 88:12 er). 
Rf = 0.28 (Pentane/diethyl ether 8:1).  
1H NMR (400 MHz, CDCl3): 7.15 (ap d, J 8.5, 2H), 6.81 (ap d, J 8.5, 2H), 3.78 (s, 3H), 3.03–
2.94 (m, 1H), 1.24 (d, J 6.9, 3H), 1.16 (s, 12H),  1.14–1.10 (ap t, J 6.8, 2H). 
13C NMR (100 MHz, CDCl3): 157.6, 141.5, 127.4, 113.5, 83.0, 55.3, 35.0, 25.1, 24.8, 24.7, 
carbons attached to boron not observed.  
11B NMR (128 MHz; CDCl3): 33.0 
IR (film): ʋ (cm–1) 2977, 2956, 2926, 2835, 1735, 1612, 1513, 1367, 1322, 1246, 1144, 1038, 
969, 829. 
HRMS (ESI) calcd. for C16H25BNaO3 [M+Na]
+ 299.1792, found 299.1780.  
[α]D26 = +18 (c 1, CHCl3). 
Chiral SFC: Whelk-01, 125 bar, 42°C, 2 mL/min, 10% co-solvent (10% IPA/Hexane); tR: 
19.98 min (minor), 20.82 min (major), er 88:12. 
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(S)-1-Methoxy-4-(1-phenylpropan-2-yl)benzene (40) 
Following a reported procedure,20 solid potassium hydroxide (33.6 
mg, 0.6 mmol), Pd(OAc)2/RuPhos (110 µL of a 1:1 solution in THF; 
0.018 M) and bromobenzene (31.6 µL, 0.3 mmol) were added to a 
solution of boronic ester 15 (80 mg, 0.2 mmol) in 1.82 mL of THF in 
a vial with a magnetic stir bar. The vial was sealed and H2O (sparged with N2 for 30 min, 0.18 
mL) was added through the teflon septum cap. The reaction mixture was then heated to 70 ºC 
and stirred for 12 h. Afterwards, the mixture was cooled to room temperature, diluted with 
diethyl ether (10 mL) and washed with H2O and brine. The organic layer was dried over 
Na2SO4, filtered, and concentrated by rotary evaporation. Purification by flash chromatography 
of the crude material gave 1,2-diarylpropane 40 (75%, 34 mg). All spectroscopic data matched 
those previously reported.21 
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3-(2,5-dimethyl-1H-pyrrol-1-yl)propyl 2,4,6-triisopropylbenzoate (41) 
 
 
  
 S42 
 
pent-4-en-1-yl 2,4,6-triisopropylbenzoate (42) 
 
 
 S43 
 
(4R)-4-((5R,8R,9S,10S,13R,14S,17R)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-
yl)pentyl 2,4,6-tritriisopropylbenzoate (43) 
 
 
 S44 
 
pent-4-yn-1-yl 2,4,6-triisopropylbenzoate (44) 
 
 
 S45 
 
3-((tert-butyldimethylsilyl)oxy)propyl 2,4,6 triisopropylbenzoate (45) 
 
 
 
 S46 
 
(R)-3-(4-methoxyphenyl)-1-(tributylstannyl)propyl 2,4,6-triisopropylbenzoate (46) 
 
 
 S47 
 
(S)-1-(Trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate (47)  
 
 
 S48 
 
(R)-3-phenyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate (48) 
 
 
 S49 
 
3-((tert-butyldimethylsilyl)oxy)-1-(trimethylstannyl)propyl 2,4,6 triisopropylbenzoate (49) 
 
 
 
 S50 
 
(R)-1-(trimethylstannyl)pent-4-en-1-yl 2,4,6-triisopropylbenzoate (50) 
 
 
 S51 
 
(R)-2-methyl-1-(trimethylstannyl)propyl 2,4,6-triisopropylbenzoate (51) 
 
 
 S52 
 
(R)-2,2'-(4-(4-methoxyphenyl)butane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (3) 
 
 
 S53 
 
(R)-1-(3,4-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butyl)-2,5-dimethyl-1H-pyrrole (5) 
 
 
 S54 
 
(R)-2,2'-(hex-5-ene-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (6) 
 
 
 S55 
 
(((3R,5R,8R,9S,10S,13R,14S,17R)-17-((2R,5S)-5,6-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexan-2-yl)-10,13-
dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)(tert-butyl)dimethylsilane (7) 
 
 
 S56 
 
2,2'-((2S,3R,5S)-6-(methoxymethoxy)-3,5-dimethylhexane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (8) 
 
 
 S57 
 
2,2'-((2R,3R,5S)-6-(methoxymethoxy)-3,5-dimethylhexane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (9) 
 
 
 S58 
 
(R)-2,2'-(hex-5-yne-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (10) 
 
 
 S59 
 
(S)-2,2'-(2-((1,1'-biphenyl)-4-yl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2 dioxaborolane)  (12) 
 
 
 S60 
 
(S)-2,2'-(2-(4-chlorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (13) 
 
 
 S61 
 
(S)-2,2'-(2-(p-tolyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (14) 
 
 
 S62 
 
(S)-2,2'-(2-(4-methoxyphenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (15) 
 
 
 S63 
 
 
(S)-2,2'-(2-(4-fluorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (16) 
 
 
 S64 
 
(S)-2,2'-(2-(2-fluorophenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (17) 
 
 
 S65 
 
(S)-2,2'-(2-(2-methoxyphenyl)propane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (18) 
 
 
 S66 
 
(R)-2,2'-(2-methyl-4-phenylbutane-1,2-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (20) 
 
 
 S67 
 
2,2'-((3S,5S)-1,7-bis(4-methoxyphenyl)heptane-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (4) 
 
 
 S68 
 
2,2'-((2S,4S)-pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (21) 
 
 
 S69 
 
2,2'-((3R,5R)-2,6-dimethylheptane-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (22) 
 
 
 S70 
 
2,2'-((5S,7S)-undeca-1,10-diene-5,7-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (23) 
 
 
 S71 
 
(6R,8R)-2,2,12,12-tetramethyl-6,8-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,11-dioxa-2,12-disilatridecane  (24) 
 
 
 S72 
 
2,2'-((2S,4S)-2,4-bis(4-methoxyphenyl)pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (25) 
 
 
 S73 
 
2,2'-((2S,4R)-2-(4-methoxyphenyl)pentane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (26) 
 
 
 S74 
 
2,2'-((2R,3S,5R)-3-(4-methoxyphenyl)-3-methylhexane-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (27) 
 
 
 S75 
 
2,2'-((2S,4S)-6-(4-methoxyphenyl)hexane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (31) 
 
 
 S76 
 
2,2'-((3S,5S)-1-(4-methoxyphenyl)-7-phenylheptane-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (32) 
 
 
 S77 
 
tert-butyl(((3R,5S)-7-(4-methoxyphenyl)-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)heptyl)oxy)dimethylsilane (33) 
 
 
 S78 
 
2,2'-((3S,5S)-1-(4-methoxyphenyl)non-8-ene-3,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (34) 
 
 
 S79 
 
2,2'-((2R,4S)-6-(4-methoxyphenyl)hexane-2,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (35) 
 
 
 S80 
 
(R)-2,2'-(2-(4-methoxyphenyl)-2-methylbutane-1,4-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (36) 
 
 
 S81 
 
(S)-1-methoxy-4-(3-methylhexa-1,5-dien-3-yl)benzene (37) 
 
 
 
 S82 
 
(S)-2-(4-methoxyphenyl)propane-1,2-diol (38) 
 
 
 
 
 S83 
 
(S)-2-(2-(4-methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (39) 
 
 
 
